Similar articles for PMID: 22077718

Year	Number of Results
1953	1
1995	1
1996	1
1997	2
1998	1
2001	1
2002	1
2003	5
2004	2
2006	1
2007	2
2008	3
2009	3
2010	9
2011	12
2012	8
2013	5
2014	9
2015	5
2016	4
2017	5
2018	4
2019	3
2021	3
2022	1
2023	1

1

Emerging concepts on the role of innate immunity in the prevention and control of HIV infection.

Ackerman ME, Dugast AS, Alter G. Ackerman ME, et al. Annu Rev Med. 2012;63:113-30. doi: 10.1146/annurev-med-050310-085221. Epub 2011 Nov 8. Annu Rev Med. 2012. PMID: 22077718 Review.

2

Systems serology for evaluation of HIV vaccine trials.

Ackerman ME, Barouch DH, Alter G. Ackerman ME, et al. Immunol Rev. 2017 Jan;275(1):262-270. doi: 10.1111/imr.12503. Immunol Rev. 2017. PMID: 28133810 Free PMC article. Review.

3

Innate gamma/delta T-cells during HIV infection: Terra relatively Incognita in novel vaccination strategies?

Agrati C, D'Offizi G, Gougeon ML, Malkovsky M, Sacchi A, Casetti R, Bordoni V, Cimini E, Martini F. Agrati C, et al. AIDS Rev. 2011 Jan-Mar;13(1):3-12. AIDS Rev. 2011. PMID: 21412385 Review.

4

HIV-specific antibody immunity mediated through NK cells and monocytes.

Kramski M, Parsons MS, Stratov I, Kent SJ. Kramski M, et al. Curr HIV Res. 2013 Jul;11(5):388-406. doi: 10.2174/1570162x113116660061. Curr HIV Res. 2013. PMID: 24191935 Review.

5

The Antibodiome-Mapping the Humoral Immune Response to HIV.

Butler AL, Fischinger S, Alter G. Butler AL, et al. Curr HIV/AIDS Rep. 2019 Apr;16(2):169-179. doi: 10.1007/s11904-019-00432-x. Curr HIV/AIDS Rep. 2019. PMID: 30903381 Free PMC article. Review.

6

Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk.

Andersen-Nissen E, Fiore-Gartland A, Ballweber Fleming L, Carpp LN, Naidoo AF, Harper MS, Voillet V, Grunenberg N, Laher F, Innes C, Bekker LG, Kublin JG, Huang Y, Ferrari G, Tomaras GD, Gray G, Gilbert PB, McElrath MJ. Andersen-Nissen E, et al. PLoS Pathog. 2021 Mar 15;17(3):e1009363. doi: 10.1371/journal.ppat.1009363. eCollection 2021 Mar. PLoS Pathog. 2021. PMID: 33720973 Free PMC article.

7

A brief history of the global effort to develop a preventive HIV vaccine.

Esparza J. Esparza J. Vaccine. 2013 Aug 2;31(35):3502-18. doi: 10.1016/j.vaccine.2013.05.018. Epub 2013 May 21. Vaccine. 2013. PMID: 23707164 Free article. Review.

8

HIV vaccine design: the neutralizing antibody conundrum.

Stamatatos L. Stamatatos L. Curr Opin Immunol. 2012 Jun;24(3):316-23. doi: 10.1016/j.coi.2012.04.006. Epub 2012 May 15. Curr Opin Immunol. 2012. PMID: 22595693 Review. No abstract available.

9

The RV144 Thai HIV vaccine trial.

Plotkin SA. Plotkin SA. Hum Vaccin. 2010 Feb;6(2):159. Epub 2010 Feb 18. Hum Vaccin. 2010. PMID: 20431337 No abstract available.

10

Opportunities to exploit non-neutralizing HIV-specific antibody activity.

Ackerman ME, Alter G. Ackerman ME, et al. Curr HIV Res. 2013 Jul;11(5):365-77. doi: 10.2174/1570162x113116660058. Curr HIV Res. 2013. PMID: 24191934 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

86 results

Results by year